8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Mar 6, 2019)

Filed March 6, 2019For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on March 6, 2019, primarily to disclose information regarding an upcoming Investor Conference scheduled for March 7, 2019. During this conference, company officers are expected to reaffirm all previously issued full-year 2019 guidance metrics. This filing also serves as a reminder to investors that the conference will be webcast live, and materials will be made available on the company's investor relations website. While this 8-K does not contain new financial results or material business updates, it highlights the company's intention to maintain its previously communicated financial outlook for 2019. Investors should note the date of the conference for any potential updates or confirmations of guidance, and access the webcast for detailed discussions. The filing also includes standard forward-looking statement disclaimers, cautioning investors about the inherent risks and uncertainties associated with future performance projections.

Key Highlights

  • 1Elevance Health (formerly Anthem, Inc.) will host an Investor Conference on March 7, 2019.
  • 2Company officers are scheduled to reaffirm full-year 2019 financial guidance metrics.
  • 3The Investor Conference will be webcast live, starting at 8:30 a.m. ET.
  • 4Conference materials will be available on the company's investor relations website (antheminc.com).
  • 5The filing emphasizes adherence to previously issued financial outlook for 2019.
  • 6Standard forward-looking statement disclosures and associated risks are included.

Frequently Asked Questions

The primary purpose of this 8-K filing is to inform investors about an upcoming Investor Conference where the company's officers will reaffirm the full-year 2019 financial guidance that was previously issued in the fourth quarter and full-year 2018 earnings release.

The Investor Conference is scheduled for March 7, 2019, beginning at 8:30 a.m. ET. The company will provide a live webcast of the conference, and related materials will be made available on Elevance Health's investor relations website at www.antheminc.com.

No, this 8-K filing does not present new financial results. Instead, it states that the company officers intend to *reaffirm* all previously issued full-year 2019 guidance metrics during the Investor Conference.

The filing includes extensive forward-looking statement disclaimers, highlighting various risks and uncertainties. These include regulatory changes (like the ACA), healthcare cost trends, provider contracting, premium rate approvals, competitive pressures, enrollment changes, data security risks, Medicare/Medicaid program risks, quality score impacts, litigation (including the ongoing dispute with Cigna), PBM agreement compliance, professional liability, dividend restrictions, indebtedness, financial strength ratings, negative publicity, IT system modernization, Blue Cross Blue Shield Association license issues, public health emergencies, M&A risks, intangible asset impairment, economic and market changes, tax law changes, employee retention, and anti-takeover provisions.